TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Nearly One Quarter of a Billion School-Aged Children Impacted by Crises Worldwide Require Urgent Support to Access Quality Education: An Increase of 35 Million Over 3 Years
On International Day of Education, Education Cannot Wait launches a new Global…
AI must be better integrated into investment process, new buy-side survey by SimCorp shows
Key findings in the 2025 InvestOps report: A new report surveying 200…
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for -Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
Treatment effects sustained through long-term follow-up of beyond 10 years in the…
FMF2024 Report: $5.4 trillion in mineral investment needed for energy transition by 2035
Emerging markets will require over 40% of investment, reflecting a shift in…
Desert Hope Treatment Center Upgrades Veteran Addiction Care with New PsychArmor Certification
LAS VEGAS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- In recognition of the…
